BPG is committed to discovery and dissemination of knowledge
Articles in Press
1/21/2026 7:55:45 AM | Browse: 2 | Download: 0
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Dyslipidemia in liver cirrhosis: Pathophysiology and emerging therapeutic approaches
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Jenyfer M Fuentes-Mendoza, Marcio J Concepción-Zavaleta, Jeny J Mendoza-Godoy, Luis A Concepción-Urteaga, Carlos O Martínez-Gutiérrez and José Paz-Ibarra |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Marcio J Concepción-Zavaleta, Grupo de Investigación en Neurociencias, Metabolismo, Efectividad Clínica y Salud Pública, Universidad Científica del Sur, 19 Panamericana Sur, Villa El Salvador, Lima 15067, Peru. mconcepcion@cientifica.edu.pe |
| Key Words |
Liver cirrhosis; Dyslipidemia; Hepatic lipid metabolism; Lipoprotein dysfunction; Cholestasis; Cardiometabolic risk |
| Core Tip |
Dyslipidemia in liver cirrhosis reflects fundamental alterations in hepatic lipid biology, including impaired apolipoprotein synthesis, defective lipoprotein export, receptor downregulation, and cholestasis-driven accumulation of atypical particles such as lipoprotein X and lipoprotein Z. These molecular disturbances generate stage-specific lipid phenotypes that challenge conventional cardiovascular risk assessment and drug targeting. Non-statin lipid-lowering agents provide mechanistically informative tools to probe these disrupted pathways; however, their effects in cirrhosis remain largely defined by pharmacologic rationale rather than direct clinical evidence. Understanding how disease stage and etiology reshape hepatic lipid handling is essential for rational application and future development of lipid-modifying strategies in cirrhotic populations. |
| Citation |
Fuentes-Mendoza JM, Concepción-Zavaleta MJ, Mendoza-Godoy JJ, Concepción-Urteaga LA, Martínez-Gutiérrez CO, Paz-Ibarra J. Dyslipidemia in liver cirrhosis: Pathophysiology and emerging therapeutic approaches. World J Hepatol 2026; In press |
 |
Received |
|
2025-10-20 01:27 |
 |
Peer-Review Started |
|
2025-10-20 01:27 |
 |
First Decision by Editorial Office Director |
|
2025-10-30 09:17 |
 |
Return for Revision |
|
2025-10-30 09:17 |
 |
Revised |
|
2025-11-12 01:00 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2026-01-21 02:38 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-01-21 07:55 |
 |
Articles in Press |
|
2026-01-21 07:55 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345